Published in Sci Rep on September 03, 2015
Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease. Can J Gastroenterol Hepatol (2016) 0.77
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med (2012) 9.46
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Rejection of the kidney allograft. N Engl J Med (2010) 3.30
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
Mechanisms of rejection: current perspectives. Transplantation (2012) 2.19
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol (2013) 1.77
A recipient risk score for deceased donor renal allocation. Am J Kidney Dis (2007) 1.70
Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci U S A (2000) 1.67
A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest (2010) 1.61
Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochem Pharmacol (2011) 1.41
Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol (2010) 1.40
The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer (2002) 1.37
Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood (2008) 1.28
Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest (2001) 1.25
Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review. Am J Kidney Dis (2008) 1.20
LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev (2003) 1.18
Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia. Clin Immunol (2005) 1.16
Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest (2001) 1.16
Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant (2003) 1.13
Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J Histochem Cytochem (2003) 1.11
Quantification and detection of DcR3, a decoy receptor in TNFR family. J Immunol Methods (2004) 1.08
Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-kappa B-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression. J Immunol (2005) 1.05
Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant (2008) 1.02
Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J Exp Med (2004) 1.02
The molecular phenotype of kidney transplants. Am J Transplant (2010) 0.92
Predictors of renal allograft histologic damage progression. J Am Soc Nephrol (2005) 0.88
TREM-1 regulates macrophage polarization in ureteral obstruction. Kidney Int (2014) 0.88
Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.86
Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice. J Am Soc Nephrol (2007) 0.85
Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys? Transplant Rev (Orlando) (2008) 0.85
EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. Biochim Biophys Acta (2013) 0.81
Significance of increased expression of decoy receptor 3 in chronic liver disease. Dig Liver Dis (2009) 0.80
Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease. Mod Pathol (2013) 0.79
Anti-Fas antibody induces apoptosis in cultured human renal interstitial fibroblasts. Chin Med J (Engl) (2001) 0.77
Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen. Transplantation (2006) 0.76
Successful treatment with sirolimus for an angiomyolipoma mimicking renal cell carcinoma in a transplanted kidney. Transpl Int (2015) 0.75
Mechanisms of the prevention and inhibition of the progression and development of NASH by genetic and pharmacological DcR3 supplementation. Hepatol Res (2017) 0.75